Balaji Amines Limited (BOM: 530999)

Market Cap	65.95B
Revenue (ttm)	15.34B
Net Income (ttm)	2.02B
Shares Out	32.40M
EPS (ttm)	62.24
PE Ratio	32.70
Forward PE	18.91
Dividend	11.00 (0.54%)
Ex-Dividend Date	Jul 4, 2024

Volume	1,970
Open	1,975.00
Previous Close	1,996.65
Day's Range	1,975.00 - 2,051.05
52-Week Range	1,965.05 - 2,736.35
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About Balaji Amines

Balaji Amines Limited engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India. The company operates in two segments, Chemicals and Hotel. It offers monomethylamine, dimethylamine, trimethylamine, monoethylamine, diethylamine, triethylamine, and dimethyl and diethyl amino ethanol; and specialty chemicals, including N-methyl pyrrolidone, morpholine, 2-pyrrolidone, N-ethyl-2-pyrrolidone, gamma-butyrolactone, dimethylformamide, acetonitrile, dimethylcarbonate, propylene...

• Industry: Industrial Organic Chemicals
• Founded: 1988
• Employees: 1,084
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 530999

Financial Performance

In 2023, Balaji Amines's revenue was 16.42 billion, a decrease of -30.31% compared to the previous year's 23.55 billion. Earnings were 2.05 billion, a decrease of -37.07%.